Science and engineering

Valeant Pharmaceuticals International, Inc. today announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P.

Better environmental DNA tests could help scientists save endangered species and find invasive ones.

Leidos (NYSE: LDOS), a global science and technology company, was awarded a task order from the U.S. Army to integrate, test and demonstrate the three complete Airborne Reconnaissance Low-Enhanced (ARL-E) systems under the ARL-E program of record

Roche announced today that OCREVUS® (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS)

Amgen today announced the submission of a sNDA to the U.S. FDA and a variation to the marketing application to the EMA to include OS data from the Phase 3 head-to-head ENDEAVOR trial in the product information for KYPROLIS® (carfilzomib).

A new multimillion pound collaborative research project led by BP and The University of Manchester could help to dramatically reduce the impact corrosion has on industry worldwide.

- AGREEMENT PROMISES MAJOR LEAP FORWARD IN AUTOMATION OF DIABETES MANAGEMENT

Scientists have used 3D printing to create a soft artificial heart from silicone. Tests with fake blood look promising.

New research suggests how droughts push plants to slow their growth.

Continental welcomes around 120 employees working in Singapore, Malaysia and Indonesia.

By 2050, the Southwest will produce significantly less cotton and forage, researchers report.

Millions of patients suffering from major depression get little relief from the first drug they are prescribed.

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC) voted that the results of ALFA-0701 demonstrated a favorable risk